Rusty Page is a strategic operations leader with over 20 years of experience navigating the complexities of the medical device industry. As the current Fractional COO of Sensydia, he oversees the high-level operational strategy required to bring sophisticated cardiac monitoring technology to market.

Throughout his career, Rusty has held pivotal leadership roles at industry-leading firms, including Bioness, Bioventus (NASDAQ: BVS) and Neuronetics (NASDAQ:STIM). His expertise lies in bridging the critical gap between early-stage R&D and commercial scale, ensuring that innovative products don’t just work—they thrive in a competitive, regulated marketplace.

A Track Record of Operational Excellence:

• M&A Due Diligence: Extensive experience leading technical and operational due diligence from both the buy-side and sell-side, ensuring organizational feasibility and seamless post-merger integration.
• Executive Strategy:  Driving growth and operational clarity as a President, COO and CTO.
• Global Manufacturing Readiness: Leveraging a deep network of global connections to accelerate prototyping and ensure manufacturing scalability for Class I, II, and III devices.
• Cybersecurity & Infrastructure: Expert in building resilient IT Backbones with a focus on a strong cybersecurity stance and audit risk mitigation.
• Digital Transformation & Systems: Adept at assessing organizational needs to implement and optimize high-impact software solutions, including CRM, ERP, and BI platforms, to ensure a robust and scalable enterprise stack. 
• Advisory & Governance: Actively seeking Board and Advisory positions (specifically Audit Committee and Strategy) to help MedTech firms navigate scaling challenges, regulatory integrity, and cybersecurity risk.